Standard BioTools
LAB
106 hedge funds and large institutions have $306M invested in Standard BioTools in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 30 reducing their positions, and 22 closing their positions.
100% more call options, than puts
Call options by funds: $20M | Put options by funds: $9.99M
22% more capital invested
Capital invested by funds: $252M → $306M (+$54.2M)
3% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 30
3% less funds holding
Funds holding: 109 → 106 (-3)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
Top Buyers
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$16.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$7.43M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$7.3M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.58M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.5M |
LAB Hedge Fund Activity: Q4 2015 in Review
106 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2015, worth a combined $306M — up 22% from $252M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of LAB and 19 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 29 added.
The largest buyer was Columbia Wanger Asset Management, opening a new position worth an estimated $17.6M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $16.2M sold.
- 106 institutional investors held Standard BioTools (LAB) as of Q4 2015, down from 109 in Q3 2015.
- Funds reported $306M of Standard BioTools stock for Q4 2015, up 22% quarter-over-quarter.
- 19 funds opened new Standard BioTools positions in Q4 2015 and 22 closed out, a net change of -3 holders.
- The largest Standard BioTools buyer in Q4 2015 was Columbia Wanger Asset Management, an estimated $17.6M added.
- The largest Standard BioTools seller in Q4 2015 was JP Morgan Chase, an estimated $16.2M sold.
Based on aggregated 13F filings for Q4 2015.